Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 10, 2004
app pub date -
Feb 26, 2003
filing date -
Feb 26, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to pharmaceutical preparations and methods for alleviating and reducing the gastrointestinal toxicity and dysfunction induced by cytoablative therapy, wherein immunomodulatory peptides are employed either alone or in combination with additional therapeutic agents. Also provided are improvements to cytoablative cancer therapy, wherein administration of the subject peptides in conjunction with cytoablative therapy enables the administration of increased maximum tolerated doses of the cytoablative agent(s) for improved efficacy and tumor response.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully